Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xi Yan

Showing results (641-650 of 662) with videos related to

Pageof 67
Sort By:
Applied and Environmental Microbiology|June 3, 2025
<i>Aeromonas</i> spp. as a fast-growing high-performance chassis for protein productionMing-Xuan Tang, Peng-Fei Meng, Ruo-Lin Huang, et al.
Chinese Journal of Integrative Medicine|January 20, 2022
Efficacy and Safety of Mulberry Twig Alkaloids Tablet for Treatment of Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical StudyLing Qu, Xiao-Chun Liang, Guo-Qing Tian, et al.
The Journal of Biological Chemistry|August 15, 2022
Identification and characterization of a novel hydroxylamine oxidase, DnfA, that catalyzes the oxidation of hydroxylamine to N<sub>2</sub>Meng-Ru Wu, Li-Li Miao, Ying Liu, et al.
Journal of Visualized Experiments : Jove|November 3, 2025
Developing Guideline Recommendations and Treatment Regimens for Acupuncture: An Example from the Clinical Practice GuidelineHui-Ze Lin, Shan-Shan Li, Yu-Tong Fei, et al.
Theranostics|July 30, 2020
Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 ImmunotherapyQianmei Yang, Gang Shi, Xiaolei Chen, et al.
Signal Transduction and Targeted Therapy|July 21, 2025
Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysisXiaoxiao Liu, Chunying Zhuang, Lei Liu, et al.
NPJ Precision Oncology|April 2, 2026
Multimodal AI model for early detection of hepatocellular carcinomaSi-Yu Jing, Xue-Liang Li, Hong Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolismYaqian Xue, Aoyuan Cui, Shuang Wei, et al.
Breast Cancer Research and Treatment|December 2, 2022
Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II studyBinghe Xu, Tao Sun, Yanxia Shi, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 2, 2024
On the Topotactic Phase Transition Achieving Superconducting Infinite-Layer NickelatesYan Li, Changjiang Liu, Hong Zheng, et al.
Pageof 67

Showing results (641-650 of 662) with videos related to

Sort By:
Pageof 67
Applied and Environmental Microbiology|June 3, 2025
<i>Aeromonas</i> spp. as a fast-growing high-performance chassis for protein productionMing-Xuan Tang, Peng-Fei Meng, Ruo-Lin Huang, et al.
Chinese Journal of Integrative Medicine|January 20, 2022
Efficacy and Safety of Mulberry Twig Alkaloids Tablet for Treatment of Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical StudyLing Qu, Xiao-Chun Liang, Guo-Qing Tian, et al.
The Journal of Biological Chemistry|August 15, 2022
Identification and characterization of a novel hydroxylamine oxidase, DnfA, that catalyzes the oxidation of hydroxylamine to N<sub>2</sub>Meng-Ru Wu, Li-Li Miao, Ying Liu, et al.
Journal of Visualized Experiments : Jove|November 3, 2025
Developing Guideline Recommendations and Treatment Regimens for Acupuncture: An Example from the Clinical Practice GuidelineHui-Ze Lin, Shan-Shan Li, Yu-Tong Fei, et al.
Theranostics|July 30, 2020
Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 ImmunotherapyQianmei Yang, Gang Shi, Xiaolei Chen, et al.
Signal Transduction and Targeted Therapy|July 21, 2025
Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysisXiaoxiao Liu, Chunying Zhuang, Lei Liu, et al.
NPJ Precision Oncology|April 2, 2026
Multimodal AI model for early detection of hepatocellular carcinomaSi-Yu Jing, Xue-Liang Li, Hong Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolismYaqian Xue, Aoyuan Cui, Shuang Wei, et al.
Breast Cancer Research and Treatment|December 2, 2022
Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II studyBinghe Xu, Tao Sun, Yanxia Shi, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 2, 2024
On the Topotactic Phase Transition Achieving Superconducting Infinite-Layer NickelatesYan Li, Changjiang Liu, Hong Zheng, et al.
Pageof 67